Targeting epidermal fatty acid binding protein for treatment of experimental autoimmune encephalomyelitis.
2015
Background
Multiple sclerosis (MS) is an autoimmune disease in which dysregulated immune cells attack myelin in the central nervous system (CNS), leading to irreversible neuronal degeneration. Our previous studies have demonstrated that epidermal fatty acid binding protein (E-FABP), widely expressed in immune cells, in particular in dendritic cells (DCs) and T lymphocytes, fuels the overactive immune responses in the mouse model of experimental autoimmune encephalomyelitis (EAE).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
30
References
16
Citations
NaN
KQI